An overview of stem cell-based clinical trials in China

Lianming Liao1, Robert Chunhua Zhao

  • 1Institute of Basic Medical Sciences & School of Basic Medicine, Center of Excellence in Tissue Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Insights

Adult stem cells (ASCs) show developmental plasticity, generating cells beyond their native tissues. This review explores therapeutic uses of bone marrow and peripheral blood ASCs, alongside regulatory considerations for clinical trials.

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Biotechnology

Background:

  • Adult stem cells (ASCs) possess self-renewal and differentiation capabilities within their specific tissues.
  • Emerging evidence indicates ASCs exhibit "developmental plasticity," generating cells outside their original tissue lineage.
  • Significant advancements have been made in utilizing ASCs for clinical applications, particularly from bone marrow and peripheral blood.

Purpose of the Study:

  • To review the therapeutic applications of adult stem cells derived from bone marrow and peripheral blood.
  • To discuss the phenomenon of "developmental plasticity" in adult stem cells.
  • To examine regulatory concerns surrounding stem cell-based clinical trials.

Main Methods:

  • Literature review focusing on adult stem cell research.
  • Analysis of studies on bone marrow and peripheral blood stem cell applications.
  • Examination of regulatory frameworks for stem cell therapies.

Main Results:

  • Adult stem cells demonstrate potential for generating diverse cell types beyond their tissue of origin.
  • Bone marrow and peripheral blood stem cells are key sources for current therapeutic strategies.
  • China is noted for rapid progress in stem cell therapeutics.

Conclusions:

  • Adult stem cell plasticity offers promising avenues for regenerative medicine.
  • Therapeutic applications of bone marrow and peripheral blood ASCs are advancing rapidly.
  • Careful consideration of regulatory oversight is crucial for safe and effective stem cell clinical trials.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...